The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical concordance study of a 17-gene liquid biopsy NGS panel for non-small cell lung cancer (NSCLC).
 
Lee Steven Schwartzberg
Honoraria - Amgen; NanoString Technologies; Novartis; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Caris Life Sciences; Genomic Health; Helsinn Therapeutics; Pfizer; Spectrum Pharmaceuticals; Tesaro
 
Emilio Esteban González
No Relationships to Disclose
 
Dolores Isla
No Relationships to Disclose
 
Michaela L. Tsai
No Relationships to Disclose
 
Fabrice Barlesi
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck Serono; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Pierre Fabre; Takeda
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Serono; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Takeda
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Pierre Fabre (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb; Roche/Genentech
 
Frederique Madeleine Penault-Llorca
Honoraria - Genomic Health
Consulting or Advisory Role - Genomic Health
 
Hidehito Horinouchi
Honoraria - Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Kyowa Hakko Kirin; Lilly; Novartis; Taiho Pharmaceutical
Consulting or Advisory Role - Lilly Japan; Novartis
Research Funding - Astellas Pharma (Inst); Chugai Pharma (Inst); Genomic Health (Inst); Merck Serono (Inst); MSD Oncology (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
 
William Johnson Irvin
Research Funding - Boston Biomedical (Inst); Genomic Health (Inst); Luitpold Pharmaceuticals (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
Carlos Escriu
Honoraria - MSD; Pfizer
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
James M. Orsini
Research Funding - Astellas Pharma; Biodesix; Celgene; Genomic Health; novartis; Paradigm; Spectrum Pharmaceuticals
 
Amparo Sanchez-Gastaldo
No Relationships to Disclose
 
John A. Keech
No Relationships to Disclose
 
Sigolene Galland-Girodet
No Relationships to Disclose
 
John Crown
Honoraria - Amgen; Boehringer Ingelheim; Eisai; Genomic Health; Pfizer; Puma Biotechnology; Seagen; Vertex
Speakers' Bureau - Eisai; Pfizer
Research Funding - Boehringer Ingelheim (Inst); Eisai (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bayer; MSD; Pfizer; Roche
 
Nashat Y. Gabrail
Honoraria - Abbvie; HERON; Johnson & Johnson; Mateon Therapeutics; Taiho Pharmaceutical
Consulting or Advisory Role - Abbvie; Bayer; HERON; Johnson & Johnson; Taiho Pharmaceutical
Speakers' Bureau - HERON; Johnson & Johnson; Taiho Pharmaceutical
Research Funding - Abbvie (Inst); Abbvie (Inst); Acerta Pharma (Inst); Acerta Pharma (Inst); Amgen (Inst); Amgen (Inst); Bayer (Inst); Bayer (Inst); BMS Brazil (Inst); BMS Brazil (Inst); Celgene (Inst); Celgene (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Halozyme (Inst); Halozyme (Inst); Incyte (Inst); Incyte (Inst); Johnson & Johnson (Inst); Johnson & Johnson (Inst); Sanofi (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
 
Kim Michelle Clark-Langone
Employment - Genomic Health
Stock and Other Ownership Interests - Genomic Health
 
Anna Bergamaschi
Employment - Genomic Health
Stock and Other Ownership Interests - Genomic Health
 
Margarita Lopatin
Employment - Genomic Health
Stock and Other Ownership Interests - Genomic Health
Patents, Royalties, Other Intellectual Property - Genomic Health
 
Christer Svedman
Employment - Genomic Health
Stock and Other Ownership Interests - Genomic Health
Patents, Royalties, Other Intellectual Property - Genomic Health
 
David Chan
Stock and Other Ownership Interests - Abbvie; Exact Sciences; Exelixis; Gilead Sciences; Loxo; Seagen; Tesaro
Consulting or Advisory Role - Counsyl
Research Funding - Genomic Health (Inst); Lexent (Inst); Natera (Inst); UCLA/TRIO (Inst)